In lung cancer models, SFN suppresses Np63 expression, which in turn reduces IL-6 secretion and inhibits Notch1 signaling activation
Given the prevalence of cardiovascular disease, type 2 diabetes, chronic kidney disease, and metabolic syndrome, it seems plausible that GLP1s reduce all-cause mortality
The increasing off-label use of GLP-1 RAs for cosmetic weight loss, often via online prescribers, adds to the urgency of evaluating the risks posed by these formulations
Less healthcare utilization for tobacco use disorder was also associated with this patient group
Studies in rats [61] also suggested that both VPA and its unsaturated metabolites inhibit -oxidation through different mechanisms, such as sequestration of CoA-SH and direct inhibition of specific enzymes in the -oxidation sequence by CoA esters, particularly 4-en-VPA-CoA